ExploreWatchlistsPricing
  1. US-listed companies
  2. Eloxx Pharmaceuticals, Inc.
  3. Financials
  4. Cash from investing

Eloxx Pharmaceuticals, Inc. (ELOX)

Market cap
$89.82M
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 20250-101.52%
Dec 31, 2022-0-103.21%
Dec 31, 20212-93.92%
Dec 31, 202034-200.80%
Dec 31, 2019-34+10475.39%
Dec 31, 2018-0+78.09%
Dec 31, 2017-0-474.74%
Jun 30, 20170+Infinity%
Jun 30, 20160-100.00%
Jun 30, 2015-0-140.13%
Jun 30, 20141-222.28%
Jun 30, 2013-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat